CAMBRIDGE, Mass., April 08, 2022 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biotechnology company…
– Data from multiple solid tumor indications confirms that MAGE-A4 is a broadly expressed cancer…
GENEVA, Switzerland, April 08, 2022 (GLOBE NEWSWIRE) — iOnctura SA, a clinical-stage oncology company targeting…
First data presentation on AGEN1571 shows strong adaptive and innate immune responses Preclinical data indicate…
Treatment with EOS-448 results in a decrease of TIGIT-positive cells in tumor biopsies, the first…
– Late-breaking presentation at AACR demonstrates potential to significantly delay onset of drug resistance to…
– ONCR-021 and ONCR-788 demonstrate robust preclinical anti-tumor efficacy following IV-administration – – vRNA Immunotherapy…
– Preclinical data demonstrate the use of gene circuits to improve the therapeutic potential of…
Preclinical data demonstrate that edited iNK cells result in increased persistence, enhanced anti-tumor activity and…
Anti-tumor data from systemic novel TREX1 inhibitors designed to activate the STING pathway selectively in…
Best Responses Include Partial Responses in Certain Patients with Non-Small Cell Lung Cancer, Metastatic Anal…
– ANV419 is very well-tolerated and demonstrates exceptional safety with strong pharmacodynamic effects and excellent…
OSLO, Norway, April 08, 2022 (GLOBE NEWSWIRE) — Nykode Therapeutics AS (Euronext Growth (Oslo): NYKD),…
– New preclinical data presented at AACR Annual Meeting 2022 – – Intravenous exosome candidate…
– Data Highlight Essential Role of GSPT1 in Sustaining Myc-induced Translational Addiction in Solid Tumors…
ZN-c3 in combination with chemotherapy demonstrated strong anti-tumor activity in a heavily pretreated population, with…
– Single Agent CFT7455 Induces Deep and Durable Degradation of IKZF1/3 and Meaningful Decreases in…
Covalent menin inhibitor BMF-219 showed strong cytotoxic activity as a single agent at similar concentrations across…
Two Additional Preclinical Proof-of-concept Posters in Ovarian and Metastatic Lung Cancer Models Also Presented at…
WTX-124 demonstrated high tumor selectivity and generated significant anti-tumor activity in a CD8+ T cell-dependent…